Ethnic and dose-dependent differences in atropine efficacy for myopia control: a systematic review and meta-analysis

医学 荟萃分析 阿托品 民族 眼科 验光服务 内科学 社会学 人类学
作者
Sayantan Biswas,Carla Lança,Daisy Kynman-Sprinks,Andrzej Grzybowski
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:: bjo-328518
标识
DOI:10.1136/bjo-2025-328518
摘要

Background/aim Clinical uncertainty remains regarding optimal atropine concentration, treatment duration and potential differences in efficacy for myopia control between Asian and non-Asian children. This systematic review and meta-analysis evaluated the efficacy of different concentrations of atropine for myopia control, comparing outcomes among East Asian, South Asian and white European children. Methods Five databases were searched for randomised controlled trials (RCTs) including children ≤16 years with myopia who received atropine treatment. 34 RCTs with ≥12 months of follow-up were included. Weighted mean differences (WMD) in spherical equivalent refraction (SER) progression and axial length (AL) elongation were pooled by atropine concentration and ethnicity. Results Compared with controls, atropine significantly reduced myopia progression across all concentrations: <0.1% (WMD in SER: 0.44 (95% CI 0.35 to 0.52) dioptres (D)/year; AL: −0.20 (95% CI −0.24 to −0.16) mm/year), 0.1% to <0.5% (0.81 (95% CI 0.50 to 1.13) D/year) and ≥0.5% (1.06 (95% CI 0.88 to 1.24) D/year; −0.36 (95% CI −0.40 to –0.33) mm/year). The pooled effect on SER and AL progression across all concentrations was greater in East Asians (0.63 (95% CI 0.50 to 0.76) D/year; −0.26 (95% CI −0.31 to −0.20) mm/year) than in South Asians (0.40 (95% CI 0.11 to 0.70) D/year; −0.13 (95% CI −0.21 to −0.05) mm/year) or white Europeans (0.18 (95% CI 0.11 to 0.25) D/year; −0.11 (95% CI −0.16 to −0.05) mm/year). Conclusion Atropine slows myopia progression in a dose-dependent manner in studies with 1–5 years. Efficacy appears greater in Asian children, particularly East Asians, who also exhibit greater photopic pupil dilation. These findings support the role of atropine in myopia control and highlight the importance of ethnicity-specific considerations when prescribing and tailoring treatment strategies. PROSPERO registration number CRD42023454104.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fang发布了新的文献求助10
1秒前
菜菜完成签到 ,获得积分10
1秒前
爱听歌的盼易完成签到,获得积分10
1秒前
XIZHENG_发布了新的文献求助10
1秒前
燕荣完成签到 ,获得积分10
2秒前
科研小小周完成签到,获得积分10
2秒前
mmz完成签到 ,获得积分10
2秒前
3秒前
一一完成签到,获得积分10
3秒前
hui发布了新的文献求助10
3秒前
自觉平露完成签到,获得积分10
3秒前
拼搏的明轩完成签到 ,获得积分10
3秒前
4秒前
嗯啊啊啊啊完成签到,获得积分20
5秒前
htykkk发布了新的文献求助10
5秒前
小小完成签到 ,获得积分10
5秒前
cs完成签到,获得积分10
6秒前
huangqian完成签到,获得积分10
6秒前
爆米花应助wisher采纳,获得10
6秒前
Owen应助fang采纳,获得10
6秒前
小薇完成签到,获得积分10
7秒前
缥缈芷珍完成签到,获得积分10
7秒前
桃桃完成签到,获得积分10
7秒前
8秒前
若什么至完成签到,获得积分10
9秒前
xuan完成签到,获得积分10
9秒前
Glileo完成签到 ,获得积分10
9秒前
耕云钓月完成签到,获得积分10
10秒前
cs发布了新的文献求助10
10秒前
10秒前
量子星尘发布了新的文献求助10
10秒前
情怀应助风评采纳,获得10
10秒前
autumn完成签到,获得积分10
10秒前
cxxx发布了新的文献求助10
10秒前
彭于晏应助后来采纳,获得30
10秒前
Jasper应助胖k采纳,获得10
11秒前
kkscanl完成签到 ,获得积分10
11秒前
11秒前
XIZHENG_完成签到,获得积分10
12秒前
缥缈柚子完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
人脑智能与人工智能 1000
花の香りの秘密―遺伝子情報から機能性まで 800
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
Pharmacology for Chemists: Drug Discovery in Context 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5606948
求助须知:如何正确求助?哪些是违规求助? 4691698
关于积分的说明 14870329
捐赠科研通 4712912
什么是DOI,文献DOI怎么找? 2543302
邀请新用户注册赠送积分活动 1508514
关于科研通互助平台的介绍 1472538